CONCORDBIO

CONCORDBIO

Concord Biotech Limited (CONCORDBIO) has announced an investment agreement with FSGE Renewable Power Private Limited, categorised under an acquisition intimation. The company will invest in a Wind Solar Hybrid Power Project designed with a wind capacity of approximately 6.3 MW AC. This strategic move, which follows a previous intimation, marks CONCORDBIO's entry into renewable energy generation. For investors, this signifies the company's commitment to sustainable practices and could lead to long-term operational efficiencies.

Concord Biotech Limited

Concord Biotech Limited has informed the exchanges about its upcoming schedule for an Analyst/Institutional Investor meet. The company's officials will participate in a Non-Deal Roadshow (NDR) to engage with investors. This outreach allows the company to interact directly with the investment community, sharing insights into its operations and strategy. While no specific financial figures or immediate decisions were disclosed, such events help foster transparency and investor relations.